RNR on NYSE
RenaissanceRe
Bermudian company
RenaissanceRe Holdings Ltd is a global provider of reinsurance and insurance that specializes in matching desirable risk with efficient capital. The Company provides property, casualty and specialty reinsurance and certain insurance solutions to customers, principally through intermediaries.3 From Wikipedia, CC BY-SA 4.0
$343.77 up 4.26 (1.25%)Price as of Oct 15, 2026 at 19:45 UTC
Last updated Oct 16, 2026.
Overview
1993Founded1
Compare with Cincinnati Financial, W. R. Berkley or Markel Corporation, or pick any stock.
- TickerRNR on NYSE1
- IndustryFire, Marine & Casualty Insurance1
- HeadquartersBermuda1
- Websitewww.renre.com
- Legal formprivate company limited by shares1
- Incorporated inBermuda5
- Business addressRenaissance House, 12 Crow Lane, Pembroke, D0 Hm195
- Filer categoryLarge accelerated filer5
See how the biggest companies compare on our leaderboards
RenaissanceRe Holdings Ltd is a global provider of reinsurance and insurance that specializes in matching desirable risk with efficient capital. The Company provides property, casualty and specialty reinsurance and certain insurance solutions to customers, principally through intermediaries. Established in 1993, and headquartered in Bermuda, RenaissanceRe has offices across North America, Europe, and the Asia-Pacific region.3
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Other costs76¢$9.8B
- Income tax3¢$396.3M
- Profit21¢$2.7B
Out of $12.8B in revenue.6
Where each dollar of operating cash went, fiscal 2025
- Dividends paid2¢$74.8M
- Share buybacks43¢$1.6B
- Kept or used elsewhere55¢$2.0B
Out of $3.7B of cash from operations.6
Financial statements
Every line of the income statement in the latest annual report, as filed.6
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Gross premiums written (Note 7) | $11.7B | $11.7B | $8.9B |
| Net premiums written (Note 7) | $9.9B | $10.0B | $7.5B |
| Decrease (increase) in unearned premiums | $31.0M | $143.5M | $3.3M |
| Net premiums earned (Note 7) | $9.9B | $10.1B | $7.5B |
| Net investment income (Note 5) | $1.7B | $1.7B | $1.3B |
| Net foreign exchange gains (losses) | -$13.5M | -$76.1M | -$41.5M |
| Equity in earnings (losses) of other ventures (Note 5) | $71.3M | $47.1M | $43.5M |
| Other income (loss) | $4.3M | $1.9M | -$6.2M |
| Net realized and unrealized gains (losses) on investments | $1.2B | -$27.8M | $414.5M |
| Total revenues | $12.8B | $11.7B | $9.1B |
| Net claims and claim expenses incurred (Notes 7 and 8) | $5.6B | $5.3B | $3.6B |
| Acquisition expenses | $2.6B | $2.6B | $1.9B |
| Operational expenses | $464.5M | $496.6M | $375.2M |
| Corporate expenses | $82.0M | $134.8M | $127.6M |
| Interest expense (Note 9) | $120.9M | $93.8M | $73.2M |
| Total expenses | $8.8B | $8.7B | $6.0B |
| Income (loss) before taxes | $4.0B | $3.0B | $3.1B |
| Income tax benefit (expense) (Note 15) | -$396.3M | -$32.6M | $510.1M |
| Net income (loss) | $3.6B | $3.0B | $3.6B |
| Net (income) loss attributable to redeemable noncontrolling interests (Note 10) | -$935.4M | -$1.1B | -$1.1B |
| Net income (loss) attributable to RenaissanceRe | $2.7B | $1.9B | $2.6B |
| Dividends on preference shares (Note 12) | -$35.4M | -$35.4M | -$35.4M |
| Net income (loss) available (attributable) to RenaissanceRe common shareholders | $2.6B | $1.8B | $2.5B |
| Net income (loss) available (attributable) to RenaissanceRe common shareholders per common share basic (in dollars per share) | $56.23 | $35.31 | $52.40 |
| Net income (loss) available (attributable) to RenaissanceRe common shareholders per common share diluted (in dollars per share) | $56.03 | $35.21 | $52.27 |
Every line of the balance sheet in the latest annual report, as filed.6
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Fixed maturity investments trading, at fair value - amortized cost $24,658,351 at December 31, 2025 (2024 - $23,750,540) (Notes 5 and 6) | $24.9B | $23.6B | |
| Short term investments, at fair value - amortized cost $4,760,027 at December 31, 2025 (2024 - $4,532,166) (Notes 5 and 6) | $4.8B | $4.5B | |
| Equity investments, at fair value (Notes 5 and 6) | $1.7B | $117.8M | |
| Other investments, at fair value (Notes 5 and 6) | $4.6B | $4.3B | |
| Investments in other ventures, under equity method (Note 5) | $121.9M | $102.8M | |
| Total investments | $36.1B | $32.6B | |
| Cash and cash equivalents | $1.7B | $1.7B | |
| Premiums receivable (Note 7) | $7.3B | $7.3B | |
| Prepaid reinsurance premiums | $993.8M | $888.3M | |
| Reinsurance recoverable (Notes 7 and 8) | $3.9B | $4.5B | $5.3B |
| Accrued investment income | $233.7M | $238.3M | |
| Deferred acquisition costs and value of business acquired | $1.5B | $1.6B | |
| Deferred tax asset | $701.9M | $701.1M | |
| Receivable for investments sold | $414.5M | $91.7M | |
| Other assets | $328.1M | $444.0M | |
| Goodwill and other intangible assets (Note 4) | $633.1M | $704.1M | |
| Total assets | $53.8B | $50.7B | |
| Reserve for claims and claim expenses (Note 8) | $22.3B | $21.3B | $20.5B |
| Unearned premiums | $6.0B | $6.0B | |
| Debt (Note 9) | $2.3B | $1.9B | |
| Reinsurance balances payable | $2.5B | $2.8B | |
| Payable for investments purchased | $533.1M | $150.7M | |
| Other liabilities | $856.3M | $1.1B | |
| Total liabilities | $34.6B | $33.2B | |
| Redeemable noncontrolling interests (Note 10) | $7.6B | $7.0B | |
| Preference shares: $1.00 par value 30,000 shares issued and outstanding at December 31, 2025 (2024 30,000) (Note 12) | $750.0M | $750.0M | |
| Common shares: $1.00 par value 43,961,539 shares issued and outstanding at December 31, 2025 (2024 50,180,987) (Note 12) | $44.0M | $50.2M | |
| Additional paid-in capital (Note 12) | $0 | $1.5B | |
| Accumulated other comprehensive income (loss) | -$12.6M | -$14.8M | |
| Retained earnings (Note 12) | $10.8B | $8.3B | |
| Total shareholders equity attributable to RenaissanceRe | $11.6B | $10.6B | $9.5B |
| Total liabilities, noncontrolling interests and shareholders equity | $53.8B | $50.7B | |
| Fixed maturity investments trading, amortized cost | $24.7B | $23.8B | |
| Short-term investments, amortized cost | $4.8B | $4.5B | |
| Preference shares, par value (in dollars per share) | $1.00 | $1.00 | |
| Preference shares, shares issued (in shares) | 30.0K shares | 30.0K shares | |
| Preference shares, shares outstanding (in shares) | 30.0K shares | 30.0K shares | |
| Common shares, par value (in dollars per share) | $1.00 | $1.00 | |
| Common shares, shares issued (in shares) | 44.0M shares | 50.2M shares | |
| Common shares, shares outstanding (in shares) | 44.0M shares | 50.2M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow in the latest annual report, as filed.6
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Net income (loss) | $3.6B | $3.0B | $3.6B |
| Amortization, accretion and depreciation | -$14.1M | $258.5M | -$134.8M |
| Equity in undistributed (earnings) losses of other ventures | -$17.2M | $9.0M | -$7.6M |
| Net realized and unrealized (gains) losses on investments | -$1.2B | -$29.4M | -$482.8M |
| Premiums receivable | $37.8M | -$9.5M | -$126.9M |
| Prepaid reinsurance premiums | -$105.4M | $36.4M | $223.4M |
| Reinsurance recoverable | $581.5M | $862.9M | $663.9M |
| Deferred acquisition costs and value of business acquired | $13.8M | $199.1M | $37.3M |
| Reserve for claims and claim expenses | $998.9M | $816.6M | -$34.7M |
| Unearned premiums | $77.8M | -$185.7M | -$227.0M |
| Reinsurance balances payable | -$263.8M | -$381.8M | -$1.0B |
| Other | -$51.7M | -$371.7M | -$579.3M |
| Net cash provided by (used in) operating activities | $3.7B | $4.2B | $1.9B |
| Proceeds from sales and maturities of fixed maturity investments trading | $12.7B | $23.5B | $21.8B |
| Purchases of fixed maturity investments trading | -$13.3B | -$26.3B | -$24.8B |
| Proceeds from sales of short term investments | $45.6B | $31.8B | $41.2B |
| Purchases of short term investments | -$45.7B | -$31.6B | -$39.3B |
| Proceeds from sales of equity investments | $1.6M | $463.0K | $566.0M |
| Purchases of equity investments | -$1.6B | -$205.0K | -$1.7M |
| Proceeds from sales of other investments | $1.0B | $1.1B | $489.7M |
| Purchases of other investments | -$1.5B | -$1.4B | -$1.2B |
| Purchases of investments in other ventures | -$1.1M | -$57.3M | -$25.3M |
| Return of investments in other ventures | $321.0K | $41.3M | $5.6M |
| Net settlements of derivatives | $564.3M | -$80.0M | -$74.3M |
| Net purchase of Validus | $0 | $0 | -$2.4B |
| Net cash provided by (used in) investing activities | -$2.2B | -$3.1B | -$3.8B |
| Dividends paid RenaissanceRe common shares | -$74.8M | -$80.8M | -$75.1M |
| Dividends paid preference shares | -$35.4M | -$35.4M | -$35.4M |
| RenaissanceRe common share repurchases | -$1.6B | -$666.9M | $0 |
| RenaissanceRe common share issuance, net of expenses | $0 | $0 | $1.4B |
| Repayment of debt | -$450.0M | -$75.0M | -$30.0M |
| Issuance of debt, net of expenses | $889.1M | $0 | $740.6M |
| Repayment of Medici Revolving Credit Facility | -$75.0M | -$75.0M | $0 |
| Drawdown of Medici Revolving Credit Facility | $75.0M | $75.0M | $75.0M |
| Subscriptions of third-party redeemable noncontrolling interest shares | $212.2M | $537.4M | $982.9M |
| Redemptions of third-party redeemable noncontrolling interest shares | -$328.4M | -$943.2M | -$400.5M |
| Taxes paid on withholding shares | -$23.5M | -$23.6M | -$20.5M |
| Net cash provided by (used in) financing activities | -$1.4B | -$1.3B | $2.6B |
| Effect of exchange rate changes on foreign currency cash | -$12.2M | -$17.4M | $5.5M |
| Net increase (decrease) in cash and cash equivalents | $54.6M | -$200.9M | $683.2M |
| Interest paid | $111.8M | $88.0M | $73.5M |
| Non-cash consideration | $0 | $0 | $285.2M |
Timeline
- 1993Founded Founded1
Recent filings
- Sep 3, 2026144
- Sep 3, 20264
- Aug 28, 2026N-PX
- Aug 27, 20264
- Aug 26, 2026144
- Aug 25, 20264
- Aug 24, 2026144
- Aug 17, 2026144
- Aug 17, 20264
- Aug 7, 202613F-HR
- Jul 28, 2026144
- Jul 28, 20264
- Jul 23, 202610-Q
- Jul 22, 20268-K
- Jun 25, 2026144
Every filing from the last three years, summarized. The full record is on SEC EDGAR.2
Links
- Websitewww.renre.com1
- X (Twitter)x.com/renreinsurance1
- WikipediaRenaissanceRe
- WikidataQ16984071
- SEC EDGARCIK 913144
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1WikidataRenaissanceRe on Wikidata
- 2SEC EDGARRenaissanceRe filings on SEC EDGAR
- 3WikipediaRenaissanceRe on Wikipedia
- 4Yahoo FinanceRNR quote
- 5SEC EDGARRenaissanceRe filings on SEC EDGAR
- 6SEC EDGARRenaissanceRe 10-K for fiscal 2025
- 7SEC EDGARRenaissanceRe 10-K for fiscal 2019
- 8SEC EDGARRenaissanceRe 10-K for fiscal 2020
- 9SEC EDGARRenaissanceRe 10-K for fiscal 2021
- 10SEC EDGARRenaissanceRe 10-K for fiscal 2022
- 11SEC EDGARRenaissanceRe 10-Q for fiscal 2026
- 12SEC EDGARRenaissanceRe 10-Q for fiscal 2026
- 13SEC EDGARRenaissanceRe 10-K for fiscal 2019